BioNTech files Form 144 for ADS and ordinary shares

BioNTech SE submitted a Form 144 notice relating to the proposed sale of American Depositary Shares representing ordinary shares and ordinary shares, no par value.

Accepted by SEC EDGAR 05/12/2026 - 06:56 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

BioNTech SE submitted a Form 144 notice relating to the proposed sale of American Depositary Shares representing ordinary shares and ordinary shares, no par value. The filing lists stock option exercise dates of 11/21/2022 and 08/09/2024 and references 05/13/2026 and Nasdaq Global Select.

Key Terms

American Depositary Shares, Stock Option Exercise, Nasdaq Global Select

3 terms

American Depositary Shares financial

"American Depositary Shares representing ordinary shares, no par value per share"

American depositary shares (ADSs) are a way for investors in the United States to buy shares of foreign companies without dealing with international markets directly. They represent ownership in a foreign company's stock and are traded on U.S. stock exchanges, making it easier for American investors to buy, sell, and own parts of companies from around the world.

Stock Option Exercise financial

"Stock Option Exercise | BioNTech SE | 11/21/2022"

A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.

Nasdaq Global Select market

"05/13/2026 | Nasdaq Global Select"

A Nasdaq Global Select listing is the highest-quality tier on the Nasdaq stock exchange, awarded to companies that meet the strictest financial, reporting and governance standards. Think of it as a “premium shelf” in a store: it signals stronger oversight, transparency and liquidity compared with lower tiers, which helps investors judge company reliability, compare risk, and may attract more institutional buyers.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What securities does BioNTech SE list on this Form 144 (BNTX)?

The filing lists American Depositary Shares representing ordinary shares and ordinary shares, no par value. It also references shares issued upon stock option exercises dated 11/21/2022 and 08/09/2024.

Who is the broker or placement agent named in the Form 144 for BNTX?

The filing names Berenberg Capital Markets LLC with an address at 1251 Avenue of the Americas, 53rd Floor, New York, NY. No further broker instructions or proceeds treatment are shown in the provided excerpt.

What date is associated with the Form 144 filing for BNTX?

The excerpt includes the date 05/13/2026 in proximity to filing details. The document also lists earlier option exercise dates of 11/21/2022 and 08/09/2024 tied to the securities.

Does the Form 144 specify where the shares will be sold for BNTX?

The excerpt references Nasdaq Global Select as the market. The filing does not provide additional distribution methods or timing in the provided content.

Do the listed securities relate to option exercises for BNTX?

Yes. The filing shows Stock Option Exercise entries tied to 11/21/2022 and 08/09/2024, indicating the shares to be sold include shares issued upon those exercises.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001803150
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	BioNTech SE
SEC File Number	001-39081
Address of Issuer	AN DER GOLDGRUBE 12 MAINZ GERMANY 55131
Phone	0049613190840
Name of Person for Whose Account the Securities are To Be Sold	Medine GmbH
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	10% Stockholder

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
American Depositary Shares representing ordinary shares, no par value per share	Berenberg Capital Markets LLC 1251 Avenue of the Americas 53rd Floor New York NY 10020	858209	80379854.94	252884261	05/13/2026	Nasdaq Global Select

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary Shares, no par value per share	11/21/2022	Stock Option Exercise	BioNTech SE			856186	11/21/2022	Stock Option Exercise
Ordinary Shares, no par value per share	08/09/2024	Stock Option Exercise	BioNTech SE			2023	08/09/2024	Stock Option Exercise

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	The filing of this Form 144 shall not be construed as an admission that the undersigned is an affiliate of the issuer.
Date of Notice	05/12/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Ugur Sahin
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)